Skip to main content
. 2016 May 18;2016(5):CD000478. doi: 10.1002/14651858.CD000478.pub4

Comparison 3. 6‐Mercaptopurine versus methotrexate.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Failure to maintain remission 1 26 Risk Ratio (M‐H, Fixed, 95% CI) 0.55 [0.31, 0.95]
2 Withdrawal due to adverse event 1 26 Risk Ratio (M‐H, Fixed, 95% CI) 1.29 [0.26, 6.46]